May 5, 2016 / 11:47 AM / in a year

BRIEF-Immunovaccine launches DPX-NEO program to develop neoepitope immunotherapies

May 5 (Reuters) - Immunovaccine Inc

* Launch of DPX-NEO program to develop neoepitope immunotherapies to expand immuno-oncology applications for depovax-based vaccines Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below